Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Ret Proto-Oncogene Antikörper (AA 702-848)

Dieses Anti-Ret Proto-Oncogene-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von Ret Proto-Oncogene in ELISA und Coat. Geeignet für Human.
Produktnummer ABIN6938317

Kurzübersicht für Ret Proto-Oncogene Antikörper (AA 702-848) (ABIN6938317)

Target

Alle Ret Proto-Oncogene (RET) Antikörper anzeigen
Ret Proto-Oncogene (RET)

Reaktivität

  • 204
  • 96
  • 73
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 178
  • 75
  • 2
  • 2
  • 1
  • 1
Maus

Klonalität

  • 175
  • 84
Monoklonal

Konjugat

  • 102
  • 18
  • 11
  • 9
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
Dieser Ret Proto-Oncogene Antikörper ist unkonjugiert

Applikation

  • 172
  • 85
  • 65
  • 65
  • 54
  • 27
  • 19
  • 17
  • 15
  • 12
  • 10
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
ELISA, Coating (Coat)

Klon

RET-2599
  • Bindungsspezifität

    • 55
    • 20
    • 18
    • 15
    • 15
    • 15
    • 11
    • 9
    • 9
    • 8
    • 8
    • 8
    • 7
    • 5
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 702-848

    Spezifität

    The Ret proto-oncogene is structurally related to the growing family of tyrosine kinase transmembrane receptors and is involved in GDNF signaling. RET expression is reported in several regions of the central nervous system; in the developing cranial nerve ganglia and a subset of cells within dorsal root ganglia, in motor neurons in the spinal cord and hindbrain, in neuro-retina and the growing tips of the renal collecting ducts in developing kidney.Alterations in RETgene are associated with diseases including papillary thyroid carcinoma, multiple endocrine neoplasia (type 2A and 2B), familial medullary thyroid carcinoma, and a congenital developmental disorder known as Hirschsprung's disease.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment (around aa 702-848) of human RET protein (exact sequence is proprietary)

    Isotyp

    IgG2b kappa
  • Applikationshinweise

    Known_Application: ELISA (Use Ab at 2-4 μg/mL for coating) (Order Ab without BSA), Optimal dilution for a specific application should be determined.

    Positive_Control: Breast, Prostate or Colon Carcinoma.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    Ret Proto-Oncogene (RET)

    Andere Bezeichnung

    RET

    Hintergrund

    Cadherin family member 12 (CDHF12), Cadherin related family member 16 (CDHR16), ELKS, HSCR1, Hydroxyaryl protein kinase, MEN2A, MEN2B, MTC1, Multiple endocrine neoplasia and medullary thyroid carcinoma 1, Oncogene RET, Proto-oncogene c-Ret, Proto-oncogene tyrosine-protein kinase receptor ret, PTC, RET, RET ELE1, RET51, RET9,RET Proto-oncogene
    Cellular localisation: Cytoplasmic, Cell Surface and Nuclear

    Molekulargewicht

    150kDa (precursor), 170kDa (Mature)

    Gen-ID

    5979, 350321

    UniProt

    P07949

    Pathways

    RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Sie sind hier:
Chat with us!